BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 10366457)

  • 1. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
    Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
    Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY; Wong LC
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT; Clarke-Pearson D; Hammond CB
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy.
    Berkowitz RS; Im SS; Bernstein MR; Goldstein DP
    J Reprod Med; 1998 Jan; 43(1):81-6. PubMed ID: 9475154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases.
    Zhu L; Song H; Yang X; Xiang Y
    Chin Med J (Engl); 1998 Nov; 111(11):1004-6. PubMed ID: 11189204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients.
    Lan Z; Hongzhao S; Xiuyu Y; Yang X
    Gynecol Oncol; 2001 Oct; 83(1):146-8. PubMed ID: 11585428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-five years' clinical experience with placental site trophoblastic tumors.
    Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
    J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Obstet Gynecol; 1982 Sep; 60(3):354-60. PubMed ID: 6289207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
    Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
    J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.